PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SNY vs. JNJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between SNY and JNJ is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.4

Performance

SNY vs. JNJ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sanofi (SNY) and Johnson & Johnson (JNJ). The values are adjusted to include any dividend payments, if applicable.

-10.00%-5.00%0.00%5.00%10.00%15.00%AugustSeptemberOctoberNovemberDecember2025
-1.97%
-5.26%
SNY
JNJ

Key characteristics

Sharpe Ratio

SNY:

-0.24

JNJ:

-0.51

Sortino Ratio

SNY:

-0.21

JNJ:

-0.66

Omega Ratio

SNY:

0.98

JNJ:

0.92

Calmar Ratio

SNY:

-0.25

JNJ:

-0.44

Martin Ratio

SNY:

-0.58

JNJ:

-1.16

Ulcer Index

SNY:

9.36%

JNJ:

6.81%

Daily Std Dev

SNY:

22.28%

JNJ:

15.39%

Max Drawdown

SNY:

-46.65%

JNJ:

-52.60%

Current Drawdown

SNY:

-15.65%

JNJ:

-15.52%

Fundamentals

Market Cap

SNY:

$123.78B

JNJ:

$349.03B

EPS

SNY:

$1.85

JNJ:

$6.05

PE Ratio

SNY:

26.69

JNJ:

23.96

PEG Ratio

SNY:

0.87

JNJ:

0.87

Total Revenue (TTM)

SNY:

$36.66B

JNJ:

$66.30B

Gross Profit (TTM)

SNY:

$25.74B

JNJ:

$45.96B

EBITDA (TTM)

SNY:

$9.62B

JNJ:

$22.61B

Returns By Period

In the year-to-date period, SNY achieves a 2.36% return, which is significantly higher than JNJ's 0.24% return. Over the past 10 years, SNY has underperformed JNJ with an annualized return of 4.19%, while JNJ has yielded a comparatively higher 6.28% annualized return.


SNY

YTD

2.36%

1M

7.58%

6M

-1.67%

1Y

-4.25%

5Y*

2.30%

10Y*

4.19%

JNJ

YTD

0.24%

1M

0.78%

6M

-5.96%

1Y

-6.83%

5Y*

2.24%

10Y*

6.28%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SNY vs. JNJ — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SNY
The Risk-Adjusted Performance Rank of SNY is 3232
Overall Rank
The Sharpe Ratio Rank of SNY is 3535
Sharpe Ratio Rank
The Sortino Ratio Rank of SNY is 2828
Sortino Ratio Rank
The Omega Ratio Rank of SNY is 2929
Omega Ratio Rank
The Calmar Ratio Rank of SNY is 3232
Calmar Ratio Rank
The Martin Ratio Rank of SNY is 3636
Martin Ratio Rank

JNJ
The Risk-Adjusted Performance Rank of JNJ is 2020
Overall Rank
The Sharpe Ratio Rank of JNJ is 2121
Sharpe Ratio Rank
The Sortino Ratio Rank of JNJ is 1818
Sortino Ratio Rank
The Omega Ratio Rank of JNJ is 1919
Omega Ratio Rank
The Calmar Ratio Rank of JNJ is 2121
Calmar Ratio Rank
The Martin Ratio Rank of JNJ is 1919
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SNY vs. JNJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sanofi (SNY) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SNY, currently valued at -0.24, compared to the broader market-2.000.002.00-0.24-0.51
The chart of Sortino ratio for SNY, currently valued at -0.21, compared to the broader market-4.00-2.000.002.004.00-0.21-0.66
The chart of Omega ratio for SNY, currently valued at 0.98, compared to the broader market0.501.001.502.000.980.92
The chart of Calmar ratio for SNY, currently valued at -0.25, compared to the broader market0.002.004.006.00-0.25-0.44
The chart of Martin ratio for SNY, currently valued at -0.58, compared to the broader market-30.00-20.00-10.000.0010.0020.00-0.58-1.16
SNY
JNJ

The current SNY Sharpe Ratio is -0.24, which is higher than the JNJ Sharpe Ratio of -0.51. The chart below compares the historical Sharpe Ratios of SNY and JNJ, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.00AugustSeptemberOctoberNovemberDecember2025
-0.24
-0.51
SNY
JNJ

Dividends

SNY vs. JNJ - Dividend Comparison

SNY's dividend yield for the trailing twelve months is around 4.13%, more than JNJ's 3.39% yield.


TTM20242023202220212020201920182017201620152014
SNY
Sanofi
4.13%4.22%3.83%4.22%3.80%3.61%3.46%4.29%3.67%4.03%3.79%4.19%
JNJ
Johnson & Johnson
3.39%3.40%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%2.64%

Drawdowns

SNY vs. JNJ - Drawdown Comparison

The maximum SNY drawdown since its inception was -46.65%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for SNY and JNJ. For additional features, visit the drawdowns tool.


-20.00%-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-15.65%
-15.52%
SNY
JNJ

Volatility

SNY vs. JNJ - Volatility Comparison

Sanofi (SNY) has a higher volatility of 9.06% compared to Johnson & Johnson (JNJ) at 5.21%. This indicates that SNY's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%AugustSeptemberOctoberNovemberDecember2025
9.06%
5.21%
SNY
JNJ

Financials

SNY vs. JNJ - Financials Comparison

This section allows you to compare key financial metrics between Sanofi and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab